Colchicine for Heart and Kidney Health in Chronic Kidney Disease

We are studying whether low-dose colchicine can help prevent heart problems and slow kidney disease in people with moderate chronic kidney disease. This trial will also look at the safety of the treatment and its effects on inflammation.

>2 years6-10 visitsConfirmation phase (III)Standard MedicinesOralCardiologyNephrology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Colchicine
Colchicine is a substance that reduces inflammation to treat and prevent gout attacks.
Opium
Opium is a natural opioid substance used to relieve severe pain and suppress coughing.
Tiemonium Methylsulphate
Tiemonium Methylsulphate is a substance that relieves abdominal and intestinal muscle spasms and cramps.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hospital Universitario Fundacion Alcorcon
Nefrology
Alcorcón, Spain
Hospital Universitario Del Sureste - Empresa Publica Hosptial Del Sureste
Nefrology
Arganda, Spain
Hospital Del Mar
Nefrology
Barcelona, Spain
Sponsor: Fundacion Para La Investigacion Biomedica Del Hospital Gregorio Maranon
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.